Clinical Trials Logo

Migraine Without Aura clinical trials

View clinical trials related to Migraine Without Aura.

Filter by:

NCT ID: NCT05211154 Recruiting - Clinical trials for Migraine Without Aura

Evaluation of the Efficacy of Diclofenac Potassium and Rimegepant for the Acute Treatment of Migraine

ATOM
Start date: May 5, 2022
Phase: Phase 4
Study type: Interventional

In a real-world population of adults with migraine, the investigators would like to investigate whether 50 mg diclofenac potassium is non-inferior to 75 mg rimegepant in terms of pain freedom at 2 hours after drug intake.

NCT ID: NCT05211050 Recruiting - Headache Clinical Trials

Effect of Sumatriptan on Levcromakalim-Induced Symptoms in Individuals With Migraine

SLIM
Start date: February 15, 2022
Phase: N/A
Study type: Interventional

The study aims to explore the effects of Sumatriptan on Levcromakalim-induced migraine in individuals with migraine without aura.

NCT ID: NCT05018572 Completed - Clinical trials for Migraine Without Aura

Digital Treatment for Migraines - a Feasibility Study

Start date: July 1, 2021
Phase: N/A
Study type: Interventional

An individualised internet-based treatment from a biopsychosocial perspective for patients with migraines in primary care has been developed within the Vastra Gotaland region in 2019. The treatment program is called Learning to live with migraines, and goes by the acronym "I am" (Internet Approach to Migraine). In a pilot study, the treatment programme and its feasibility in primary care will be evaluated. It is hoped that the intervention "I am" can educate patients about their illness and help the patient manage migraine attacks so that the likelihood of difficulty and frequency of migraine attacks does not increase, as well as provide an increased function and quality of life.

NCT ID: NCT04968093 Completed - Migraine With Aura Clinical Trials

Mindfulness for Adolescents for CM and HFEM

MINDKIDS
Start date: January 2016
Phase: N/A
Study type: Interventional

Chronic Migraine (CM) and High Frequency Episodic Migraine (HFEM) without Aura affect adolescents' lives in terms of reduced health, reduced ability to perform daily chores and reduced quality of life. The use of pharmacological prophylaxis in these patients warrants caution, whereas the use of behavioral treatments is gaining support in literature. The main aim of MINDKIDS trial is to test the effect of a seven weekly group sessions of guided mindfulness-based meditation program on 12-month headache frequency reduction, medications intake, disability, anxiety, depression, catastrophizing, and caregivers' burden. This is a single-arm study. All patients will participate to seven weekly guided sessions (60 minutes each) of guided mindfulness meditation, which is aimed to teach and make direct practice with skills intended to enhance sustained, non-judgmental present moment awareness. The intervention's main topics are: posture education; breath use and control; guided body scan; work with sounds; tension release; guided imagery; decentralization of thoughts. Each session is conducted by a neurologist and a psychologist expert in mindfulness practice. During the sessions, patients are asked to close their eyes and focus their attention on the breathing so that they can concentrate on the present moment and on all the sensations. Patients were educated to promote a healthy lifestyle: regular physical activity, avoiding skipping meals, hydration, maintain a regular sleep/wake pattern at least 7-8 hours per night.

NCT ID: NCT04940390 Completed - Migraine Clinical Trials

A Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study to Assess STS101 in the Acute Treatment of Migraine

SUMMIT
Start date: June 30, 2021
Phase: Phase 3
Study type: Interventional

Study STS101-007 is a randomized, double-blind, parallel group, placebo-controlled, multicenter study to evaluate the efficacy, safety, and tolerability of single doses of STS101 (dihydroergotamine nasal powder) in the acute treatment of migraine.

NCT ID: NCT04936061 Terminated - Migraine Clinical Trials

Transnasal Cooling for Migraine

Start date: October 14, 2021
Phase: N/A
Study type: Interventional

This is a prospective, double-blind, sham-controlled, randomized study to assess the safety, tolerability, and optimal dose of the COOLSTAT Transnasal Thermal Regulating Device for acute treatment of migraine. The hypothesis is that evaporative cooling induced by the CoolStat using only ambient, dry air will reduce the pain and other symptoms of migraine headaches during an acute migraine episode.

NCT ID: NCT04853797 Recruiting - Headache Clinical Trials

Effect of Ivabradine on Levcromakalim-Induced Symptoms in Individuals With Migraine Without Aura (ILIM)

ILIM
Start date: April 16, 2021
Phase: N/A
Study type: Interventional

This study aims to explore the effect of Ivabradine on Levcromakalim-induced migraine in individuals with migraine without aura.

NCT ID: NCT04766762 Recruiting - Clinical trials for Migraine Without Aura

A Randomized Controlled Trial of Acupuncture in Treating Migraine

Start date: April 21, 2021
Phase: N/A
Study type: Interventional

Migraine without aura is a common kind of nervous system diseases that can easily cause recurrent headache, leading to severe impacts on quality of life and health care costs. Current therapeutic options for migraine without aura mainly include flunarizine hydrochloride that can relieve vasospasm. Nevertheless, the efficacy of flunarizine hydrochloride is always limited by inevitable side effects, which result in poor compliance of patients. Moreover, for some most suffering patients, the control of pain is often unsatisfactory despite of the administration of complex treatment combinations. As a non-pharmaceutical therapy, acupuncture is widely used for a wide range of pain conditions. Thus, it might be an alternative treatment for migraine without aura. The aim of this randomized controlled trial is to investigate the efficacy and safety of acupuncture therapy in patients with migraine without aura from the perspective of Regulating Ying and Wei.

NCT ID: NCT04726592 Recruiting - Migraine Clinical Trials

Efficacy of CLORazepate for the Treatment of MIGraine Attack in the Emergency Room

Start date: July 8, 2021
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the efficacy of clorazepate in addition to the usual medication for treating migraine attack in the emergency room

NCT ID: NCT04715685 Recruiting - Migraine Clinical Trials

Mind Body Balance for Pediatric Migraine

Start date: March 9, 2021
Phase: N/A
Study type: Interventional

This study uses a factorial research design to evaluate a nurse delivered mind body intervention using different doses of 3 treatment components to determine the optimized treatment for headache day reduction.